KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Times Interest Earned (2018 - 2026)

Neogenomics filings provide 13 years of Times Interest Earned readings, the most recent being -$30.5 for Q1 2026.

  • On a quarterly basis, Times Interest Earned fell 77.37% to -$30.5 in Q1 2026 year-over-year; TTM through Mar 2026 was -$38.89, a 185.08% decrease, with the full-year FY2025 number at -$30.88, down 121.82% from a year prior.
  • Times Interest Earned hit -$30.5 in Q1 2026 for Neogenomics, down from -$22.39 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$5.06 in Q4 2022 to a low of -$284.24 in Q3 2022.
  • Median Times Interest Earned over the past 5 years was -$18.14 (2024), compared with a mean of -$38.58.
  • Biggest five-year swings in Times Interest Earned: tumbled 827.61% in 2022 and later surged 94.95% in 2023.
  • Neogenomics' Times Interest Earned stood at -$5.06 in 2022, then crashed by 118.41% to -$11.05 in 2023, then decreased by 2.55% to -$11.33 in 2024, then plummeted by 97.64% to -$22.39 in 2025, then tumbled by 36.21% to -$30.5 in 2026.
  • The last three reported values for Times Interest Earned were -$30.5 (Q1 2026), -$22.39 (Q4 2025), and -$44.8 (Q3 2025) per Business Quant data.